RAMP1 as a novel prognostic biomarker in pan-cancer and osteosarcoma.
Receptor activity modifying protein 1 (RAMP1) facilitates the localization of the calcitonin-like receptor (CLR) to the plasma membrane, but its role in osteosarcoma (OS) remains unclear. We evaluated the RAMP1 expression and prognostic value across different cancers, studying tumor immune infiltrat...
Main Authors: | Long Xie, Weiwei Xiao, Hangqi Fang, Guoqiang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0292452&type=printable |
Similar Items
-
RAMP1 as a novel prognostic biomarker in pan-cancer and osteosarcoma
by: Long Xie, et al.
Published: (2023-01-01) -
Pan-cancer analysis revealed prognosis value and immunological relevance of RAMPs
by: Sha Yang, et al.
Published: (2024-02-01) -
Pan-cancer analysis shows that IBSP is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including osteosarcoma
by: Boyu Pan, et al.
Published: (2023-06-01) -
LRH1 Acts as an Oncogenic Driver in Human Osteosarcoma and Pan-Cancer
by: Yang Song, et al.
Published: (2021-03-01) -
Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
by: Weiwei Liu, et al.
Published: (2022-08-01)